Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1991-1-8
|
pubmed:abstractText |
C-1027, a new macromolecular peptide antitumor antibiotic produced by a Streptomyces strain, was extremely cytotoxic to cultured cancer cells and markedly inhibited the growth of transplantable tumors in mice. As determined by tritium-labeled precursor-incorporation assay, C-1027 strongly inhibited DNA and RNA synthesis in hepatoma BEL-7402 cells without affecting protein synthesis. After incubation with the hepatoma cells for 4 h, IC50 values for [3H]-thymidine and [3H]-uridine incorporation were 0.00012 and 0.00032 microM, respectively. After 30 min incubation, C-1027 showed much stronger inhibition of [3H]-thymidine incorporation than did Adriamycin, mitomycin C or methotrexate, even at a concentration 10,000 times lower. The effect of C-1027 on pBR322 DNA suggested that the drug could cause single- or double-strand scission of DNA. As determined by flow cytometry, C-1027 delayed the progression of hepatoma cells through the S-phase and blocked the cells at G2+M. Cytological study showed that C-1027 caused a drastic reduction of the mitotic index within 1 h and that an overshot of the mitotic index occurred at 48 h. Our results indicate that C-1027 is an interesting compound with highly potent activity on cellular DNA.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Aminoglycosides,
http://linkedlifedata.com/resource/pubmed/chemical/Anti-Bacterial Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Antibiotics, Antineoplastic,
http://linkedlifedata.com/resource/pubmed/chemical/C 1027,
http://linkedlifedata.com/resource/pubmed/chemical/DNA,
http://linkedlifedata.com/resource/pubmed/chemical/Enediynes,
http://linkedlifedata.com/resource/pubmed/chemical/Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Thymidine,
http://linkedlifedata.com/resource/pubmed/chemical/Uridine
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0344-5704
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
27
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
41-6
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:2173979-Aminoglycosides,
pubmed-meshheading:2173979-Anti-Bacterial Agents,
pubmed-meshheading:2173979-Antibiotics, Antineoplastic,
pubmed-meshheading:2173979-Carcinoma, Hepatocellular,
pubmed-meshheading:2173979-Cell Cycle,
pubmed-meshheading:2173979-Cell Division,
pubmed-meshheading:2173979-DNA,
pubmed-meshheading:2173979-DNA Damage,
pubmed-meshheading:2173979-Enediynes,
pubmed-meshheading:2173979-Flow Cytometry,
pubmed-meshheading:2173979-Humans,
pubmed-meshheading:2173979-Mitotic Index,
pubmed-meshheading:2173979-Proteins,
pubmed-meshheading:2173979-Thymidine,
pubmed-meshheading:2173979-Tumor Cells, Cultured,
pubmed-meshheading:2173979-Uridine
|
pubmed:year |
1990
|
pubmed:articleTitle |
Mode of action of C-1027, a new macromolecular antitumor antibiotic with highly potent cytotoxicity, on human hepatoma BEL-7402 cells.
|
pubmed:affiliation |
Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences, Beijing.
|
pubmed:publicationType |
Journal Article
|